|22.00||-0.94 / -4.10%|
Data as of 4:00pm ET
|22.00||0.00 / 0.00%|
The 6 analysts offering 12-month price forecasts for Theravance Inc have a median target of 28.00, with a high estimate of 47.00 and a low estimate of 7.00. The median estimate represents a +27.27% increase from the last price of 22.00.
The current consensus among 7 polled investment analysts is to Hold stock in Theravance Inc. This rating has held steady since July, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.